Israel Poised to Become Medical Cannabis Powerhouse

Already known as a leading global player in clinical testing, Israeli growers have been leveraging clinical trials to produce new strains and providing expertise to deliver medical-grade cannabis products.

“Israeli growers have agreements with companies in the USA, Canada, Czech Republic and Australia. Israel has the oldest and largest regulated medical cannabis programs in the world with over 22,000 registered patients,” said Saul Kaye, founder of iCan and CannaTech, a yearly cannabis innovation and investor summit in Israel, according to the Crunch.

Kaye also explained Hebrew University has a huge bank of cannabis patents, making Israeli the number one country for research and clinical studies in world.

“In the U.S., the DEA does not allow for the transportation of raw materials,” said Dr. Tamir Gedo, CEO of Breath of Life, a manufacturer of pharmacy grade API for companies looking to conduct clinical trials. “A company in New York cannot import enough raw cannabis to conduct the clinical trials.”